RNA Transcriptome Profiling Test Market

1. Executive Summary

2. Industry Introduction, including Taxonomy and Market Definition

3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments

4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034

• 5.1. by Component Type
• 5.2. by Method Type
• 5.3. by Application
• 5.4. by End User

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Component Type

• 6.1. Consumables
  • 6.1.1. Reagents
  • 6.1.2. Kits
  • 6.1.3. Dyes
• 6.2. Instruments
  • 6.2.1. RT PCR
  • 6.2.2. Microarray
  • 6.2.3. Sanger Sequencing Platform
  • 6.2.4. RNA Sequencing Platform
• 6.3. Software
• 6.4. Services

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Method Type

• 7.1. Conventional Methods
  • 7.1.1. RNA-DNA Hybridization Measurements
  • 7.1.2. Subtractive Hybridization
  • 7.1.3. Differential Display
• 7.2. High Throughput Methods
  • 7.2.1. Hybridization-based method using Micro Array Technology
  • 7.2.2. Sequencing based
    • 7.2.2.1. RNA sequencing
    • 7.2.2.2. Serial analysis of gene expression (SAGE)
    • 7.2.2.3. Massively Parallel Signature Sequencing (MPSS)

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application

• 8.1. Cancer Research
• 8.2. Complex Disease Biomarker Identification
• 8.3. Agrigenomics
• 8.4. RNA-Based Drug Response Biomarker Discovery
• 8.5. Others

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User

• 9.1. Hospital Based Laboratories
• 9.2. Diagnostic Centers
• 9.3. Academic and Research Institutes
• 9.4. Contract research Organizations (CROs)
• 9.5. Others

10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region

• 10.1. North America
• 10.2. Latin America
• 10.3. Western Europe
• 10.4. Eastern Europe
• 10.5. East Asia
• 10.6. South Asia & Pacific
• 10.7. MEA

11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

17. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries

18. Sales Forecast 2024 to 2034, by Component Type, by Method Type, by Application, and by End User for 30 Countries

19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard

20. Company Profile

• 20.1. Agilent Technologies, Inc.
• 20.2. F. Hoffmann-La Roche AG
• 20.3. Illumina, Inc.
• 20.4. Thermo Fisher Scientific, Inc.
• 20.5. QIAGEN N.V.
• 20.6. Bio-Rad Laboratories, Inc.
• 20.7. Pacific Biosciences of California, Inc.
• 20.8. Eurofins Scientific
• 20.9. Merck KGaA
• 20.10. Promega Corporation
• 20.11. 10x Genomics
• 20.12. Twist Bioscience
• 20.13. Bruker Spatial Biology
• 20.14. Cepheid